Horizon Therapeutics Public Ltd Co Restructuring Charges
Horizon Therapeutics Public Ltd Co reported Restructuring Charges of $1.08 million for the 12-month period ending 2019-12-31, per its 10-K filed 2022-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2022-03-01
- Horizon Therapeutics Public Ltd Co restructuring charges for the quarter ending 2019-12-31 was -$145.00K.
- Horizon Therapeutics Public Ltd Co restructuring charges for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- Horizon Therapeutics Public Ltd Co restructuring charges for the quarter ending 2019-06-30 was $1.30M, a 377.94% increase year-over-year.
- Horizon Therapeutics Public Ltd Co restructuring charges for the quarter ending 2019-03-31 was -$79.00K, a 108.32% decline year-over-year.
- Horizon Therapeutics Public Ltd Co restructuring charges for fiscal 2019 was $1.08M.
- Horizon Therapeutics Public Ltd Co restructuring charges for fiscal 2018 was -$1.46M, a 712.55% decline from fiscal 2017.
- Horizon Therapeutics Public Ltd Co restructuring charges for fiscal 2017 was $239.00K, a 98.69% decline from fiscal 2016.
- Horizon Therapeutics Public Ltd Co restructuring charges for fiscal 2016 was $18.25M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$145.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$145.00K derived: sum of 2 quarters · filed 2022-03-01 | $1.16M derived: sum of 3 quarters · filed 2022-03-01 | $1.08M 10-K · filed 2022-03-01 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $1.30M derived: sum of 2 quarters · filed 2020-11-02 | $1.22M 10-Q · filed 2020-11-02 | -$1.72M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $1.30M 10-Q · filed 2020-08-05 | $1.22M 10-Q · filed 2020-08-05 | -$1.72M derived: sum of 3 quarters · filed 2021-02-24 | -$1.47M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | -$79.00K 10-Q · filed 2020-05-06 | -$3.02M derived: sum of 2 quarters · filed 2021-02-24 | -$2.77M derived: sum of 3 quarters · filed 2021-02-24 | -$2.49M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | -$2.94M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$2.69M derived: sum of 2 quarters · filed 2021-02-24 | -$2.41M derived: sum of 3 quarters · filed 2021-02-24 | -$1.46M 10-K · filed 2021-02-24 |
| 2018-09-30 | $254.00K 10-Q · filed 2019-11-06 | $526.00K derived: sum of 2 quarters · filed 2019-11-06 | $1.48M 10-Q · filed 2019-11-06 | $5.93M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $272.00K 10-Q · filed 2019-08-07 | $1.22M 10-Q · filed 2019-08-07 | $5.68M derived: sum of 3 quarters · filed 2020-02-26 | $4.56M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $950.00K 10-Q · filed 2019-05-08 | $5.41M derived: sum of 2 quarters · filed 2020-02-26 | $4.29M derived: sum of 3 quarters · filed 2020-02-26 | $1.19M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $4.46M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $3.34M derived: sum of 2 quarters · filed 2020-02-26 | $239.00K derived: sum of 3 quarters · filed 2020-02-26 | $239.00K 10-K · filed 2020-02-26 |
| 2017-09-30 | -$1.12M 10-Q · filed 2018-11-07 | -$4.22M derived: sum of 2 quarters · filed 2018-11-07 | -$4.22M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | -$3.10M 10-Q · filed 2018-08-08 | -$3.10M 10-Q · filed 2018-08-08 | ||
| 2016-12-31 | $18.25M 10-K · filed 2019-02-27 |